
{"id":16438,"date":"2026-02-25T10:40:16","date_gmt":"2026-02-25T10:40:16","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/?post_type=case-study&#038;p=16438"},"modified":"2026-02-25T12:39:12","modified_gmt":"2026-02-25T12:39:12","slug":"recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway","status":"publish","type":"case-study","link":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/","title":{"rendered":"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-dark-blue-500-color has-text-color has-link-color has-text-2-xl-font-size wp-elements-2fb718622de4e9c039b4147cefef566c\">\u03b2-catenin (CTNNB1) is a multifunctional protein that plays a pivotal role in the canonical Wnt signalling pathway \u2013 a highly conserved signalling pathway which governs critical biological processes such as cell proliferation, differentiation and migration. Mutations in CTNNB1 can disrupt this regulation, leading to aberrant activation of Wnt signalling and contributing to oncogenesis (Liu, J. <em>et al.<\/em> 2022). Consequently, CTNNB1 has been identified as a therapeutic target of interest.<\/h2>\n\n\n\n<p>In the absence of Wnt ligands, \u03b2-catenin is targeted for proteasomal degradation by a multiprotein \u00ab\u00a0destruction complex\u00a0\u00bb composed of APC (adenomatous polyposis coli), AXIN, GSK-3\u03b2 (glycogen synthase kinase 3 beta), and CK1 (casein kinase 1). This complex phosphorylates \u03b2-catenin at specific serine and threonine residues\u2014primarily encoded by exon 3 of the CTNNB1 gene\u2014marking it for ubiquitination and subsequent degradation (Clevers &amp; Nusse, 2012), preventing its accumulation and nuclear translocation.<\/p>\n\n\n\n<p>Conversely, activation of the Wnt pathway by extracellular Wnt ligands, leads to the destruction complex being inhibited. This inhibition prevents \u03b2-catenin phosphorylation and degradation, allowing it to accumulate in the cytoplasm and eventually translocate into the nucleus. Inside the nucleus, \u03b2-catenin interacts with TCF\/LEF family transcription factors, initiating the transcription of target genes that regulate cell proliferation, survival, and differentiation. This mechanism is essential for normal development and tissue homeostasis but can be hijacked in cancer (Gao, C. <em>et al. <\/em>2018).<\/p>\n\n\n\n<p>There are multiple CTNNB1 crystal structures deposited within the protein data bank (PDB). Expression, purification, and crystallography of a truncated CTNNB1 construct which included the full C-terminus following the armadillo repeats was achieved by Xing, Y. et al. (2008) (PDB: 2Z6H) (Figure 1. cyan). Whereas, Sampietro, J. et al. (2006) have published the structure of a mutant CTNNB1 crystal structure (PDB: 2GL7) (Figure 1. green). The structures highlight the tight bundles of alpha-helices at the core of the protein providing a scaffold during the Wnt signalling pathway.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-style-rounded is-style-rounded--1\"><img loading=\"lazy\" decoding=\"async\" width=\"873\" height=\"362\" src=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Structure-of-truncated-B-Catenein-CTNNB1-.webp\" alt=\"\" class=\"wp-image-16437\" srcset=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Structure-of-truncated-B-Catenein-CTNNB1-.webp 873w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Structure-of-truncated-B-Catenein-CTNNB1--300x124.webp 300w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Structure-of-truncated-B-Catenein-CTNNB1--768x318.webp 768w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Structure-of-truncated-B-Catenein-CTNNB1--640x265.webp 640w\" sizes=\"(max-width: 873px) 100vw, 873px\" \/><figcaption class=\"wp-element-caption\"><strong>Figure 1<\/strong>. Overlay of truncated mutant CTNNB1 (PDB: 2GL7, green) and truncated CTNNB1 (PDB: 2Z6H, cyan) shown in cartoon format. <\/figcaption><\/figure>\n\n\n\n<p>Within the <a href=\"https:\/\/www.sygnaturediscovery.com\/scientific-solutions\/protein-science-structural-biology\/\" target=\"_blank\" rel=\"noreferrer noopener\">Protein Science and Structural Biology department<\/a> at Sygnature Discovery, we have successfully produced high-quality recombinant CTNNB1 protein to support a wide range of client projects. Our expertise in protein expression and purification enables us to offer multiple construct lengths and tag combinations tailored for diverse downstream applications (Figure 2).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-style-rounded is-style-rounded--2\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"475\" src=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin-1024x475.webp\" alt=\"\" class=\"wp-image-16436\" srcset=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin-1024x475.webp 1024w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin-300x139.webp 300w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin-768x357.webp 768w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin-640x297.webp 640w, https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/Purified-samples-of-different-forms-of-B-Catenin.webp 1036w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\"><strong>Figure 2<\/strong>. SDS PAGE of  purified samples of different CTNNB1 protein constructs<\/figcaption><\/figure>\n\n\n\n<p>We are looking to build on this success and are currently working to establish a crystallization systems for two of our CTNNB1 constructs. To date we have crystals diffracting to  to 3.1 \u00c5 but there is a bit more work to be done to generate a robust system&#8230;.watch this space.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-blue-400-color has-text-color has-link-color has-text-xl-font-size wp-elements-3d136d1396e420a9571072cc9699ccf2\"><strong>References<\/strong><\/h3>\n\n\n\n<p>Clever, H. and Nusse, R. Wnt\/B-Catenin Signalling and Disease. Cell. 149 (6). 1192-1205. (2012)<\/p>\n\n\n\n<p>Gao, C. et al. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget 9, 5492 (2018).<\/p>\n\n\n\n<p>Liu, J. et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduction and Targeted Therapy 7 (1). 1\u201323. (2022).<\/p>\n\n\n\n<p>Sampietro, J. <em>et al.<\/em> Crystal Structure of a beta-Catenin\/BCL9\/Tcf4 Complex. Molecular Cell. 24 (2). 293 \u2013 300. (2006)<\/p>\n\n\n\n<p>Xing, Y. et al. Crystal Structure of a Full-Length \u03b2-Catenin. Structure 16 (3). 478-487. (2008).<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":16435,"template":"","category":[702,704],"resource_tag":[660,662],"class_list":["post-16438","case-study","type-case-study","status-publish","has-post-thumbnail","hentry","category-protein-expression-and-purification","category-structural-biology","resource_tag-protein-purification","resource_tag-x-ray"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature<\/title>\n<meta name=\"description\" content=\"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature\" \/>\n<meta property=\"og:description\" content=\"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T12:39:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/2z6h.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"678\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/\",\"name\":\"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2z6h.webp\",\"datePublished\":\"2026-02-25T10:40:16+00:00\",\"dateModified\":\"2026-02-25T12:39:12+00:00\",\"description\":\"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2z6h.webp\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2z6h.webp\",\"width\":1000,\"height\":678},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/case-study\\\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature","description":"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/","og_locale":"fr_CA","og_type":"article","og_title":"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature","og_description":"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/","og_site_name":"Sygnature","article_modified_time":"2026-02-25T12:39:12+00:00","og_image":[{"width":1000,"height":678,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/2z6h.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/","name":"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/2z6h.webp","datePublished":"2026-02-25T10:40:16+00:00","dateModified":"2026-02-25T12:39:12+00:00","description":"In this case study we present our success with the expression and purification of different constructs of \u03b2-catenin (CTNNB1) protein.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/2z6h.webp","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/2z6h.webp","width":1000,"height":678},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/case-study\/recombinant-%ce%b2-catenin-ctnnb1-expression-and-purification-provides-an-early-handle-for-therapeutic-targeting-of-the-wnt-signalling-pathway\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Recombinant \u03b2-catenin (CTNNB1) expression and purification provides an early handle for therapeutic targeting of the Wnt signalling pathway"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/case-study\/16438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/case-study"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/case-study"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/case-study\/16438\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/16435"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=16438"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=16438"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=16438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}